Crispr Therapeutics shares owned by Interchange Capital Partners
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Interchange Capital Partners
from 13F filings
Historical chart of Interchange Capital Partners investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Interchange Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Interchange Capital Partners
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $489k | 7.1k | 68.61 |
2023-12-31 | $414k | 6.6k | 62.46 |
2023-09-30 | $262k | 5.8k | 45.39 |
2023-06-30 | $323k | 5.4k | 59.42 |
2023-03-31 | $218k | 4.8k | 45.23 |
2022-09-30 | $373k | 5.7k | 65.28 |
2022-06-30 | $453k | 7.5k | 60.71 |
2022-03-31 | $460k | 7.3k | 62.66 |
2021-12-31 | $476k | 6.3k | 75.77 |
2021-03-31 | $1.0M | 7.6k | 133.72 |
2020-12-31 | $1.5M | 9.8k | 153.08 |
More positions owned by Interchange Capital Partners
View all positions for Interchange Capital Partners